FDA has removed certain bulk drug substances that were placed on the category two list and has announced it will consult the Pharmacy Compounding Advisory Committee (PCAC) for potential future inclusion of RFK Jr. & claimed regenerative peptides like BPC 157 The Niche Alternative Treatments: Identifying Options After FDA Reclassification of Specific Peptides Bergen Total Health When will the FDA reclassify BPC 157 to Category 1 Octagon AI